3Lin W D,Lu S L,Qing C,et al.The relationship of diabetic non-healing wound and AGEs[J].Chin J Clin Rehab,2003,7 (17):2491-2493.
4Lin C L,Wang J Y,Huang Y T,et al.Wnt/beta-catenin signaling modulates survival of high glucose stressed mesang cells[J].J Am Soc Nephrol,2006,17 (10):2812-2820.
6Cbeon S S,Wei Q,Gurong A,et al.Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing[J].FASEB J,2006,20(6):692-701.
7Yamaguchi Y,Passeron T,Hoashl T,et al.Dickkopf 1 (DKK1)regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in kerafinocytes[J].FAsEB J,2008,22(4):1009-1020.
8Chang Z Z,Shang Y C,Maiese K.Vascular injury during elevated glucose can be mitigated by erythrepoietin and Writ signaling[J].Curt Neurovasc Res,2007,4(3):194-204.
7Jeschke M G, Klein D, Hemdon D N. Insulin treatment improves the systemic inflammatory reaction to severe trauma [J]. Ann Surg, 2004,239(4) :553-560.
8Swati Datta, Arshia Qaadir, Griselda Villanueva, et al. Oncedaily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure : a randomized clinical trial[ J ]. Endocrine Practice,2007, 13(3) :225-230.
9Wang F, Carabino JM, Vergara CM. Insulin glargine: a systematic review of a long-acting insulin analogue[ J]. Clin Ther, 2003,25 (6) :1541-1576.
10Davies M, Storms F, Shutler S, et al. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine[ J]. Diabetes Care,2005,28(6) :1282-1289.
